BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

127 related articles for article (PubMed ID: 35725314)

  • 21. A prospective study of expectant observation as primary therapy for neuroblastoma in young infants: a Children's Oncology Group study.
    Nuchtern JG; London WB; Barnewolt CE; Naranjo A; McGrady PW; Geiger JD; Diller L; Schmidt ML; Maris JM; Cohn SL; Shamberger RC
    Ann Surg; 2012 Oct; 256(4):573-80. PubMed ID: 22964741
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Surgical management and outcome of locoregional neuroblastoma: comparison of the Childrens Cancer Group and the international staging systems.
    Haase GM; Atkinson JB; Stram DO; Lukens JN; Matthay KK
    J Pediatr Surg; 1995 Feb; 30(2):289-94; discussion 295. PubMed ID: 7738753
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Neuroblastoma in adults and adolescents: an indolent course with poor survival.
    Franks LM; Bollen A; Seeger RC; Stram DO; Matthay KK
    Cancer; 1997 May; 79(10):2028-35. PubMed ID: 9149032
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Survival effect of complete surgical resection of the primary tumor in patients with metastatic, high-risk neuroblastoma in a large Canadian cohort.
    Seemann NM; Erker C; Irwin MS; Lopushinsky SR; Kulkarni K; Fernandez CV; Romao RLP
    Pediatr Blood Cancer; 2023 Jun; 70(6):e30286. PubMed ID: 36975166
    [TBL] [Abstract][Full Text] [Related]  

  • 25. The Pediatric Oncology Group experience with the international staging system criteria for neuroblastoma. Member Institutions of the Pediatric Oncology Group.
    Castleberry RP; Shuster JJ; Smith EI
    J Clin Oncol; 1994 Nov; 12(11):2378-81. PubMed ID: 7964953
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Impact of complete resection on survival of patients with large neuroblastoma].
    Lobato R; Queizán A; Martínez L; Díaz M; Gámez M; Tovar JA
    Cir Pediatr; 2000 Jan; 13(1):14-5. PubMed ID: 12602016
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Proliferation marker KI-S5 discriminates between favorable and adverse prognosis in advanced stages of neuroblastoma with and without MYCN amplification.
    Krams M; Hero B; Berthold F; Parwaresch R; Harms D; Rudolph P
    Cancer; 2002 Feb; 94(3):854-61. PubMed ID: 11857322
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Locoregional control in infants with neuroblastoma: role of radiation therapy and late toxicity.
    Paulino AC; Mayr NA; Simon JH; Buatti JM
    Int J Radiat Oncol Biol Phys; 2002 Mar; 52(4):1025-31. PubMed ID: 11958898
    [TBL] [Abstract][Full Text] [Related]  

  • 29. The impact of surgical radicality on outcome in childhood neuroblastoma.
    von Schweinitz D; Hero B; Berthold F
    Eur J Pediatr Surg; 2002 Dec; 12(6):402-9. PubMed ID: 12548494
    [TBL] [Abstract][Full Text] [Related]  

  • 30. The role of surgery in stage IV neuroblastoma.
    Castel V; Tovar JA; Costa E; Cuadros J; Ruiz A; Rollan V; Ruiz-Jimenez JI; Perez-Hernández R; Cañete A
    J Pediatr Surg; 2002 Nov; 37(11):1574-8. PubMed ID: 12407542
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Is the prognosis of stage 4s neuroblastoma in patients 12 months of age and older really excellent?
    Iehara T; Hiyama E; Tajiri T; Yoneda A; Hamazaki M; Fukuzawa M; Hosoi H; Sugimoto T; Sawada T
    Eur J Cancer; 2012 Jul; 48(11):1707-12. PubMed ID: 22305511
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Maintaining Outstanding Outcomes Using Response- and Biology-Based Therapy for Intermediate-Risk Neuroblastoma: A Report From the Children's Oncology Group Study ANBL0531.
    Twist CJ; Schmidt ML; Naranjo A; London WB; Tenney SC; Marachelian A; Shimada H; Collins MH; Esiashvili N; Adkins ES; Mattei P; Handler M; Katzenstein H; Attiyeh E; Hogarty MD; Gastier-Foster J; Wagner E; Matthay KK; Park JR; Maris JM; Cohn SL
    J Clin Oncol; 2019 Dec; 37(34):3243-3255. PubMed ID: 31386611
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Outcome after surgery alone or with restricted use of chemotherapy for patients with low-risk neuroblastoma: results of Children's Oncology Group study P9641.
    Strother DR; London WB; Schmidt ML; Brodeur GM; Shimada H; Thorner P; Collins MH; Tagge E; Adkins S; Reynolds CP; Murray K; Lavey RS; Matthay KK; Castleberry R; Maris JM; Cohn SL
    J Clin Oncol; 2012 May; 30(15):1842-8. PubMed ID: 22529259
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Age Dependency of the Prognostic Impact of Tumor Genomics in Localized Resectable
    Ambros IM; Tonini GP; Pötschger U; Gross N; Mosseri V; Beiske K; Berbegall AP; Bénard J; Bown N; Caron H; Combaret V; Couturier J; Defferrari R; Delattre O; Jeison M; Kogner P; Lunec J; Marques B; Martinsson T; Mazzocco K; Noguera R; Schleiermacher G; Valent A; Van Roy N; Villamon E; Janousek D; Pribill I; Glogova E; Attiyeh EF; Hogarty MD; Monclair TF; Holmes K; Valteau-Couanet D; Castel V; Tweddle DA; Park JR; Cohn S; Ladenstein R; Beck-Popovic M; De Bernardi B; Michon J; Pearson ADJ; Ambros PF
    J Clin Oncol; 2020 Nov; 38(31):3685-3697. PubMed ID: 32903140
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Biologic variables in the outcome of stages I and II neuroblastoma treated with surgery as primary therapy: a children's cancer group study.
    Perez CA; Matthay KK; Atkinson JB; Seeger RC; Shimada H; Haase GM; Stram DO; Gerbing RB; Lukens JN
    J Clin Oncol; 2000 Jan; 18(1):18-26. PubMed ID: 10623689
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Salvage rates after progression of high-risk neuroblastoma with a soft tissue mass.
    Murphy JM; Lim II; Farber BA; Heaton TE; Basu EM; Roberts SS; Modak S; Kushner BH; LaQuaglia MP
    J Pediatr Surg; 2016 Feb; 51(2):285-8. PubMed ID: 26651282
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Neuroblastoma: a 20-year experience in a UK regional centre.
    Salim A; Mullassery D; Pizer B; McDowell HP; Losty PD
    Pediatr Blood Cancer; 2011 Dec; 57(7):1254-60. PubMed ID: 21523901
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Outcomes and complications of surgery in patients with intermediate-risk neuroblastoma: experience from an Indian tertiary Cancer Centre.
    Qureshi SS; Bhagat M; Harris C; Chinnaswamy G; Vora T; Kembhavi S; Prasad M; Ramadwar M; Shetty O; Laskar S; Khanna N; Amin N; Talole S
    Pediatr Surg Int; 2018 Apr; 34(4):435-442. PubMed ID: 29487992
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Age, Diagnostic Category, Tumor Grade, and Mitosis-Karyorrhexis Index Are Independently Prognostic in Neuroblastoma: An INRG Project.
    Sokol E; Desai AV; Applebaum MA; Valteau-Couanet D; Park JR; Pearson ADJ; Schleiermacher G; Irwin MS; Hogarty M; Naranjo A; Volchenboum S; Cohn SL; London WB
    J Clin Oncol; 2020 Jun; 38(17):1906-1918. PubMed ID: 32315273
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Posttreatment complications in pediatric cervical neuroblastoma: A retrospective case series at a tertiary cancer center.
    Lopez J; Subramanian T; Durell J; Levyn H; Wong R; Shah J; LaQuaglia MP; Gerstle JT
    J Surg Oncol; 2024 Feb; 129(2):219-223. PubMed ID: 37850570
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.